Price target
78.080.00 0.00%
The 25 analysts offering 1 year price forecasts for 1CG have a max estimate of — and a min estimate of —.
Analyst rating
Based on 31 analysts giving stock ratings to 1CG in the past 3 months.
EPS
0.00
Reported
Estimate
Reported
Estimate
Surprise
Revenue
0.00
Reported
Estimate
Reported
Estimate
Surprise
This info isn't a recommendation for what you should personally do, so please don't take the data as investment advice. As with any trade, always look first, then leap. Read more in the Terms of Use.
Frequently Asked Questions
1CG EPS for the last quarter is −1.33 EUR despite the estimation of −1.26 EUR. In the next quarter EPS is expected to reach −1.32 EUR. Track more of CRISPR THERAPEUTICS LTD financials and stay on top of what is up with the company.
In the next quarter CRISPR THERAPEUTICS LTD revenue is expected to reach 13.08 M EUR. Check out CRISPR THERAPEUTICS LTD revenue and earnings and make informed decisions.
According to analysts, 1CG price target is 78.08 EUR with a max estimate of 183.84 EUR and a min estimate of 27.71 EUR. Check if this forecast comes true in a year, meanwhile watch CRISPR THERAPEUTICS LTD stock price chart and keep track of the current situation with 1CG news and stock market news.
We've gathered opinions of 31 analysts rating 1CG stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as buy. Note that it's not a trading advice — your own analysis is still required.